Key facts
- PathSpot’s last known valuation is $78.0M.
- It has raised $23.3M; the latest was Later Stage VC ($2.0M) in Aug 2024.
- Notable investors include Alumni Ventures, Techstars, Right Side Capital Management, Valor Equity Partners, Wavemaker Pacific Growth (Singapore) — 25 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 25 names
- ·Watchlist + deal alerts for PathSpot
- ·The full record, as it builds
Funding rounds
No funding rounds for PathSpot are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PathSpot
Developer of a contaminant detection device designed to detect pathogens that cause food-borne diseases. The company's device uses algorithms for filtering, processing, and analyzing to indicate the presence of harmful bacteria on the work surface, cooking utensils, and employees' hands, enabling clients to insulate themselves from the threat of illness by instantly detecting invisible signs of bacteria and viruses that cause foodborne diseases.
- Sector
- Information Technology
- HQ
- New York, NY, United States
- Founded
- 2017
- Employees
- 24
- Website
- pathspot.com/
- Ownership
- Privately Held (backing)
PathSpot doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PathSpot shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PathSpot in its N-PORT filings yet. We sweep new filings monthly.